Our Journals
touchREVIEWS in Infectious Diseases is an international, peer-reviewed, free-to-access journal dedicated to the timely publication of review articles, original research, case reports, and editorials in the field of infectious diseases.
The journal is of interest to infectious diseases specialists, virologists, immunologists, epidemiologists and other health care professionals with an interest in infectious diseases.
All articles are subject to peer review, and must adhere to the ICMJE, GPP-3Â and COPE guidelines.
Editor-in-Chief: Amesika Nyaku, Assistant Professor, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Electronic ISSN: 2755-113XÂ Â DOI:Â doi.org/10.17925
Established: January 2022 Frequency: Annual
Don’t forget to register to be notified about articles as soon as they are published
Explore our Latest Articles
Tuberculous mastitis (TM) is a rare chronic granulomatous disease predominantly caused by Mycobacterium tuberculosis.1 TM accounts for less than 0.1% of all breast diseases worldwide, whereas it is more common in endemic regions (3–4.5%).2,3 TM is more prevalent in the reproductive age ...
It is my pleasure to introduce this issue of touchREVIEWS in Infectious Diseases for 2025, which features a diverse range of reviews and editorials addressing the scientific, clinical and policy dimensions of infectious disease management in a rapidly evolving global landscape. ...
This article provides an overview of nirmatrelvir/ritonavir (Paxlovid®; Pfizer, New York, NY, USA), an oral antiviral agent manufactured by Pfizer, used for treating mild-to-moderate coronavirus disease 2019 (COVID-19). Herein, we summarize the drug’s pharmacology, including its mechanism of action ...
At the start of 2025, the world was healthier and safer because of the USA’s longstanding commitment to biomedical research.1–3 Further progress was on the horizon as healthcare providers delivered new interventions targeting the leading infectious causes of illness and ...
People living with HIV (PLWH) are living longer, healthier lives due to the effectiveness of antiretroviral therapy (ART) and sustained viral suppression.1–4 Studies conducted in Europe and North America indicate that individuals who initiate ART early and achieve adequate immune ...
Despite significant progress in reducing the burden of HIV, it remains one of the major challenges to public health worldwide. In 2023, there were 40 million adults living with HIV, and more than 1 million new HIV diagnoses were reported worldwide.1Â In the ...
A double-stranded DNA virus of the Orthopoxvirus family, mpox (formerly monkeypox), continues to infect people daily, following the 2022 global outbreak.1 Two clades (clade 1 and clade 2) have been identified, with the 2022 outbreak caused by a subclade of clade 2, referred to as ...
Welcome to the latest edition of touchREVIEWS in Infectious Diseases, where we continue our mission to deliver insightful, cutting-edge perspectives in infectious disease diagnosis and management. This issue offers an array of topics spanning diagnostics, service delivery innovations and preventive ...
Highlights Determining infection and multidrug resistance (MDR) rates continuously helps to detect the problem to be solved, including outbreaks. Cleaning and disinfection play an important role in preventing MDR and evaluating and correcting the process for better results. MDR control ...
The expansion of HIV treatment access during the past two decades, particularly in low- and middle-income countries, stands as a significant accomplishment in the field of public health.1Â Currently, there are an estimated 30 million people on antiretroviral treatment for HIV ...
Respiratory syncytial virus (RSV) is often of increased concern in the autumn and winter months, especially for women who are pregnant, or those with newborns.1Â Worldwide, RSV is the second leading cause of death (second to malaria) in children during ...
Vaginal symptoms are one of the most common reasons for women accessing acute healthcare in the USA.1Â Vaginitis is most commonly evaluated based on clinical observations, including assessment of discharge characteristics, vaginal pH and, in some settings, microscopic examination of ...
We are excited to introduce the latest edition of touchREVIEWS in Infectious Diseases. Our mission is to bring you thought-provoking interviews, reviews, editorials, case studies and original research within the realm of infectious diseases. We aspire to engage infectious disease ...
The treatment of people with HIV (PWH)/hepatitis B virus (HBV) co-infection, especially those who have additional comorbidities requiring multiple drug therapies can be problematic. Bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) is a co-formulated medication consisting of two components ...
By sharing, listening and gaining an understanding of the real-life experiences of individuals living with a condition, clinicians and patients can better work together to improve care and outcomes and shape the healthcare system and policy of the future. Patient ...
Despite being the most severe form of viral hepatitis, there is no FDA-approved therapy for chronic hepatitis delta (CHD).1 Patients with CHD can progress to cirrhosis, as early as 5–10 years after infection. Further complications can also develop, such as esophageal ...
Article highlights Erythrasma is a common chronic superficial cutaneous bacterial infection caused by Corynebacterium minutissimum when conditions are conducive. Corynebacterium minutissimum produces coproporphyrin III (a phosphor) that emits a coral pink fluorescence under Wood’s lamp and helps confirm the ...
HIV is a significant global health issue for which there is no cure. However, the availability of antiretroviral therapy (ART) has made it possible to effectively treat and prevent HIV infection, leading to a considerable decrease in associated deaths and ...
touchINFECTIOUS DISEASES
Register Now!
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
- Save your progress for video
- Keep track of your CME credits
- Add personalised learning notes
- Receive updates from course leaders and faculty
- Be the first to hear about new and exciting interactive learning opportunities
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
